Bone Morphogenetic Protein: Is There Still a Role in Orthopedic Trauma in 2017?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28577779.
- Also identified by DOI 10.1016/j.ocl.2017.03.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Approximately 10 years ago bone morphogenic protein (BMP) was seen as a miraculous adjuvant to assist with bone growth. However, in the face of an increasing number of complications and a lack of understanding its long-term effects, it is unclear what role BMP has in the current treatment of orthopedic trauma patients. This article reviews the current recommendations, trends, and associated complications of BMP use in fracture care.
Medical subject headings
- Bone Morphogenetic Proteins
- Fractures, Bone
- Fractures, Ununited
- Long Term Adverse Effects